Global recognition honors Immunotec’s decades-long commitment to scientific discovery and continued advancement of Immunocal® research.
THE WOODLANDS, TX, UNITED STATES, October 23, 2026 /EINPresswire.com/ — Immunotec, a global health and wellness company with nearly three decades of experience advancing glutathione science and a portfolio of 81 patents, has been named a Gold Globee® Award winner for Achievement in Research & Development in the 18th Annual 2026 Globee® Awards for Innovation, also known as the Golden Bridge Awards®.
The international awards program recognizes achievements in innovation across industries, organizations, teams, products, services and professional disciplines. Immunotec’s Gold recognition honors the company’s long-term investment in scientific research and its continued work to expand understanding of the potential applications of Immunocal®, its proprietary cysteine-rich whey protein isolate.
“For nearly 30 years, science has been at the heart of the company,” said Mauricio Domenzain, CEO of Immunotec. “This recognition is especially meaningful because it honors not simply one discovery, but our long-term commitment to asking important questions, investing in rigorous research and continuing to explore what is possible through glutathione science. We are proud of how far this research has come and incredibly excited about where it may lead next.”
Immunocal®, Immunotec’s flagship product, is a patented, cysteine-rich whey protein isolate developed to provide the body with cysteine, a critical building block for the production of glutathione, one of the body’s most important naturally occurring antioxidants. Since its development, Immunotec has continued to invest in scientific research examining Immunocal and glutathione across a broad range of health-related areas.
That commitment has grown into a research platform spanning more than four decades of scientific investigation, more than $25 million invested in research, 92 scientific publications, including 26 blinded human trials, and collaborations involving 275 researchers and 169 institutions across 20 countries.
More recently, Immunotec’s research and intellectual property portfolio has expanded into neurological and neuropsychiatric areas.
In April 2024, Immunotec was granted a U.S. patent related to the use of its cysteine-rich whey protein isolate in autism following a randomized, double-blind, placebo-controlled human study in young children. In June 2026, the company received two additional U.S. patents covering research involving resilience to traumatic brain injury and increased Reelin expression in the prefrontal cortex in schizophrenia.
Additional preclinical research published in the Journal of Alzheimer’s Disease in 2025 further explored the relationship between Immunocal, glutathione, Reelin and markers associated with Alzheimer’s disease.
Together, these developments reflect Immunotec’s evolution from the development of a nutritional product into a broader scientific research platform focused on understanding how supporting the body’s glutathione system may have applications across multiple areas of human health.
The Globee Awards for Innovation recognize measurable achievements in innovation across organizations of all sizes and industries worldwide. Winners are selected through a merit-based, score-driven evaluation process involving participating professionals from around the world.
The Achievement in Research & Development category specifically recognizes organizations for long-term investment in scientific discovery and technical experimentation.
“This Gold Globee belongs to the researchers, scientific collaborators and teams who have continued to advance this work year after year,” Domenzain added. “Our history has always been grounded in science, but what makes this moment particularly exciting is that our research story is still being written.”
About Immunotec
Immunotec is a global health and wellness company dedicated to helping people live healthier, more fulfilling lives through science-backed nutritional products and an entrepreneurial business opportunity. Its flagship product, Immunocal®, is a proprietary cysteine-rich whey protein isolate developed to support the body’s natural production of glutathione. Backed by decades of scientific research, Immunotec serves customers and independent Consultants across 30 global markets.
For more information, visit Immunotec.com.
About the Globee® Awards
The Globee® Awards organize merit-based, data-driven business awards programs with worldwide participation. Across multiple awards programs, the Globee Awards recognize achievements spanning industries, organizations, products, services, teams and professionals. Winners are determined through a structured evaluation process involving participating professionals from around the world.
Axel Herrera
Immunotec
+52 56 6228 0249
Visit us on social media:
LinkedIn
Facebook
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
